Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Biochem Biophys Res Commun ; 595: 76-81, 2022 03 05.
Article in English | MEDLINE | ID: mdl-35101666

ABSTRACT

L-enantiomers of antimicrobial peptides (AMPs) are sensitive to proteolytic degradation; however, D-enantiomers of AMPs are expected to provide improved proteolytic resistance. The present study aimed to comparatively investigate the in vitro antibacterial activity, trypsin and serum stability, toxicity, and in vivo antibacterial activity of L-enantiomeric bovine NK2A (L-NK2A) and its D-enantiomeric NK2A (D-NK2A). Circular dichroism spectroscopy of D-NK2A and L-NK2A in anionic liposomes showed α-helical structures and the α-helical conformation of D-NK2A was a mirror image of L-NK2A. Both D-NK2A and L-NK2A displayed minimal in vitro and in vivo toxicities. RP-HPLC and mass spectrometry analyses revealed that D-NK2A, but not L-NK2A, was resistant to trypsin digestion. D-NK2A and L-NK2A showed similar in vitro bacterial killing activities against Histophilus somni. Slightly reduced antibacterial activity was observed when D-NK2A and L-NK2A were pre-incubated with serum. Confocal and transmission electron microscopic findings confirmed that both peptides induced disruption of bacterial inner- and outer-membranes. Improved survivals with D-NK2A treatment were observed when compared to L-NK2A in a murine model of acute H. somni septicemia. We conclude that antibacterial activity and mode of action of NK2A are not chiral specific. With further optimization, D-NK2A may be a viable AMP candidate to combat bacterial infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antimicrobial Peptides/pharmacology , Pasteurellaceae Infections/prevention & control , Pasteurellaceae/drug effects , Proteolipids/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Antimicrobial Peptides/chemistry , Cattle , Circular Dichroism , Kaplan-Meier Estimate , Mice , Microscopy, Electron, Transmission , Pasteurellaceae/physiology , Pasteurellaceae/ultrastructure , Pasteurellaceae Infections/microbiology , Protein Stability , Protein Structure, Secondary , Proteolipids/chemistry , Stereoisomerism
2.
J Biol Chem ; 290(36): 22101-10, 2015 Sep 04.
Article in English | MEDLINE | ID: mdl-26195629

ABSTRACT

ETS1 is the archetype of the ETS transcription factor (TF) family. ETS TFs share a DNA-binding domain, the ETS domain. All ETS TFs recognize a core GGA(A/T) binding site, and thus ETS TFs are found to redundantly regulate the same genes. However, each ETS TF has unique targets as well. One prevailing hypotheses explaining this duality is that protein-protein interactions, including homodimerization, allow each ETS TF to display distinct behavior. The behavior of ETS1 is further regulated by autoinhibition. Autoinhibition apparently modulates ETS1 DNA binding affinity, but the mechanism of this inhibition is not completely understood. We sought to characterize the relationship between DNA binding and ETS1 homodimer formation. We find that ETS1 interrogates DNA and forms dimers even when the DNA does not contain an ETS recognition sequence. Mutational studies also link nonspecific DNA backbone contacts with dimer formation, in addition to providing a new role for the recognition helix of ETS1 in maintaining the autoinhibited state. Finally, in showing that residues in the DNA recognition helix affect autoinhibition, we define a new function of ETS1 autoinhibition: maintenance of a monomeric state in the absence of DNA. The conservation of relevant amino acid residues across all ETS TFs indicates that the mechanisms of nonspecific DNA interrogation and protein oligomer formation elucidated here may be common to all ETS proteins that autoinhibit.


Subject(s)
DNA/chemistry , Protein Multimerization , Proto-Oncogene Protein c-ets-1/chemistry , Transcription Factors/chemistry , Binding Sites/genetics , Binding, Competitive , Circular Dichroism , DNA/metabolism , DNA Footprinting/methods , Deoxyribonuclease I/metabolism , Humans , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Mutation , Oligonucleotides/chemistry , Oligonucleotides/metabolism , Protein Binding , Proto-Oncogene Protein c-ets-1/genetics , Proto-Oncogene Protein c-ets-1/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism
3.
Prion ; 12(1): 63-71, 2018 01 02.
Article in English | MEDLINE | ID: mdl-29310497

ABSTRACT

Misfolding of the normally folded prion protein of mammals (PrPC) into infectious fibrils causes a variety of diseases, from scrapie in sheep to chronic wasting disease (CWD) in cervids. The misfolded form of PrPC, termed PrPSc, or in this case PrPCWD, interacts with PrPC to create more PrPCWD. This process is not clearly defined but is affected by the presence and interactions of biotic and abiotic cofactors. These include nucleic acids, lipids, glycosylation, pH, and ionic character. PrPC has been shown to act as a copper-binding protein in vivo, though it also binds to other divalents as well. The significance of this action has not been conclusively elucidated. Previous reports have shown that metal binding sites occur throughout the N-terminal region of PrPC. Other cations like manganese have also been shown to affect PrPC abundance in a transcript-independent fashion. Here, we examined the ability of different divalent cations to influence the stability and in vitro conversion of two variants of PrP from elk (L/M132, 26-234). We find that copper and zinc de-stabilize PrP. We also find that PrP M132 exhibits a greater degree of divalent cation induced destabilization than L132. This supports findings that leucine at position 132 confers resistance to CWD, while M132 is susceptible. However, in vitro conversion of PrP is equally suppressed by either copper or zinc, in both L132 and M132 backgrounds. This report demonstrates the complex importance of ionic character on the PrPC folding pathway selection on the route to PrPSc formation.


Subject(s)
Amyloid/metabolism , Copper/metabolism , Deer/metabolism , Manganese/metabolism , Prion Proteins/metabolism , Wasting Disease, Chronic/metabolism , Zinc/metabolism , Animals , Cations, Divalent , Circular Dichroism , Humans , Prion Proteins/genetics , Prion Proteins/isolation & purification , Protein Folding , Protein Stability , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism
4.
PLoS One ; 13(5): e0197677, 2018.
Article in English | MEDLINE | ID: mdl-29771981

ABSTRACT

Antimicrobial peptides (AMPs) are a diverse group of molecules which play an important role in the innate immune response. Bovine NK-lysins, a type of AMP, have been predominantly found in the granules of cytotoxic T-lymphocytes and NK-cells. Bovine NK-lysin-derived peptides demonstrate antimicrobial activity against various bacterial pathogens, including several involved in bovine respiratory disease complex (BRDC) in cattle; however, such studies are yet to be performed with one important contributor to the BRDC, Mycoplasma bovis. Therefore, the goal of this study was to assess the antimicrobial activity of bovine NK-lysin-derived peptides on M. bovis. Thirty-mer synthetic peptides corresponding to the functional region helices 2 and 3 of bovine NK-lysins NK1, NK2A, NK2B, and NK2C were evaluated for killing activity on M. bovis isolates. Among four peptides, NK2A and NK2C showed the highest antimicrobial activity against the M. bovis isolates tested. All four NK-lysin peptides induced rapid plasma membrane depolarization in M. bovis at two concentrations tested. However, based on propidium iodide uptake, only NK2A and NK2C appeared capable of causing structural damage to M. bovis plasma membrane. Confocal microscopy, flow cytometry, and transmission electron microscopy further suggested NK-lysin-induced damage to the plasma membrane. Taken together, the findings in this study suggest that plasma membrane depolarization alone was insufficient to induce lethality, but disruption/permeabilization of the M. bovis plasma membrane was the cause of lethality.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Mycoplasma bovis/drug effects , Peptides/chemical synthesis , Proteolipids/chemistry , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bovine Respiratory Disease Complex/drug therapy , Bovine Respiratory Disease Complex/microbiology , Cattle , Cell Membrane/drug effects , Cell Polarity/drug effects , Microbial Viability/drug effects , Mycoplasma Infections/drug therapy , Mycoplasma Infections/microbiology , Mycoplasma bovis/isolation & purification , Peptides/chemistry , Peptides/pharmacology , Protein Structure, Secondary
5.
PLoS One ; 7(4): e34563, 2012.
Article in English | MEDLINE | ID: mdl-22509323

ABSTRACT

We reported previously that 933W repressor apparently does not cooperatively bind to adjacent sites on DNA and that the relative affinities of 933W repressor for its operators differ significantly from that of any other lambdoid bacteriophage. These findings indicate that the operational details of the lysis-lysogeny switch of bacteriophage 933W are unique among lambdoid bacteriophages. Since the functioning of the lysis-lysogeny switch in 933W bacteriophage uniquely and solely depends on the order of preference of 933W repressor for its operators, we examined the details of how 933W repressor recognizes its DNA sites. To identify the specificity determinants, we first created a molecular model of the 933W repressor-DNA complex and tested the predicted protein-DNA interactions. These results of these studies provide a picture of how 933W repressor recognizes its DNA sites. We also show that, opposite of what is normally observed for lambdoid phages, 933W operator sequences have evolved in such a way that the presence of the most commonly found base sequences at particular operator positions serves to decrease, rather than increase, the affinity of the protein for the site. This finding cautions against assuming that a consensus sequence derived from sequence analysis defines the optimal, highest affinity DNA binding site for a protein.


Subject(s)
Bacteriophages , DNA/metabolism , Models, Molecular , Repressor Proteins/metabolism , Viral Proteins/metabolism , Base Sequence , DNA/genetics , Protein Binding , Protein Conformation , Repressor Proteins/chemistry , Substrate Specificity , Viral Proteins/chemistry
6.
J Cell Sci ; 122(Pt 12): 2024-33, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19454477

ABSTRACT

Cell proliferation requires close coordination of cell growth and division to ensure constant cell size through the division cycles. IQGAP1, an effector of CDC42 GTPase has been implicated in the modulation of cell architecture, regulation of exocytosis and in human cancers. The precise mechanism underlying these activities is unclear. Here, we show that IQGAP1 regulates cell proliferation, which requires phosphorylation of IQGAP1 and binding to CDC42. Expression of the C-terminal region of IQGAP1 enhanced cellular transformation and migration, but reduced the cell size, whereas expression of the N-terminus increased the cell size, but inhibited cell transformation and migration. The N-terminus of IQGAP1 interacts with mTOR, which is required for IQGAP1-mediated cell proliferation. These findings are consistent with a model where IQGAP1 serves as a phosphorylation-sensitive conformation switch to regulate the coupling of cell growth and division through a novel CDC42-mTOR pathway, dysregulation of which generates cellular transformation.


Subject(s)
Cell Proliferation , Protein Kinases/metabolism , cdc42 GTP-Binding Protein/metabolism , ras GTPase-Activating Proteins/physiology , Animals , Cell Cycle/genetics , Cytokinesis/genetics , HeLa Cells , Humans , Mice , Models, Biological , NIH 3T3 Cells , Phosphorylation , Protein Binding , Protein Kinases/physiology , Protein Structure, Tertiary/genetics , Protein Structure, Tertiary/physiology , Signal Transduction/physiology , TOR Serine-Threonine Kinases , cdc42 GTP-Binding Protein/physiology , ras GTPase-Activating Proteins/chemistry , ras GTPase-Activating Proteins/genetics , ras GTPase-Activating Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL